MDWD

MediWound Ltd. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website mediwound.com
Employees(FY) 83
ISIN IL0011316309

Performance

-8.07%

1W

+8.86%

1M

+45.55%

3M

+122.62%

6M

+70.3%

YTD

+67.34%

1Y

Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Advanced Technical Analysis

Technical Analysis of MDWD 2024-05-10

Overview:

In analyzing the technical indicators for MDWD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...

See more ...

Recent News & Updates

2024-04-24 20:00
MediWound to Present New Data from EscharEx Phase II Studies at Three Leading Wound Care Conferences(Globenewswire)
2024-04-16 19:24
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?(Zacks)
2024-03-24 21:55
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?(Zacks)
2024-03-24 20:50
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'(Zacks)
2024-03-20 23:54
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023(Investorplace)
2024-03-20 20:25
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates(Zacks)
2024-03-20 19:25
MediWound: Q4 Earnings Snapshot(Yahoo Finance)
2024-03-20 19:00
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update(Globenewswire)
2024-03-13 20:00
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-03-05 19:46
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?(Zacks)
2024-02-11 18:00
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx vs. SANTYL within the ChronEx Phase II Randomized Controlled Study(Globenewswire)
2024-02-04 19:00
MediWound to Participate in Two Upcoming Investor Conferences(Globenewswire)
2024-01-14 20:55
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross(Zacks)
2024-01-09 05:21
Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet(Yahoo Finance)
2024-01-08 19:48
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions(Yahoo Finance)
2024-01-08 18:00
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns(Globenewswire)
2023-12-27 18:00
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army(Globenewswire)
2023-12-20 19:00
MediWound Announces Peer-Reviewed Publication of EscharEx Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads(Globenewswire)
2023-12-12 20:55
Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to Trade(Yahoo Finance)
2023-11-26 20:55
Does MediWound (MDWD) Have the Potential to Rally 223.05% as Wall Street Analysts Expect?(Yahoo Finance)
2023-11-20 18:12
MediWound: Q3 Earnings Snapshot(Yahoo Finance)
2023-11-20 18:02
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update(Globenewswire)
2023-11-20 18:00
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer(Globenewswire)
2023-11-13 19:02
MediWound to Report Third Quarter 2023 Financial Results(Globenewswire)
2023-11-12 18:00
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid to Treat Pediatric Patients(Globenewswire)
2023-11-07 18:00
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid Distribution in Europe(Globenewswire)
2023-10-10 18:00
MediWound Announces Collaboration with 3M on EscharEx Phase III Study(Globenewswire)
2023-10-08 19:34
MediWound Deploys NexoBrid for Emergency Supply(Globenewswire)
2023-10-03 01:20
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024(Yahoo Finance)
2023-09-28 20:00
MediWound (MDWD) Surges 18.2%: Is This an Indication of Further Gains?(Zacks)

Page 1 of 4

previousnext